Expression alterations define unique molecular characteristics of spinal ependymomas

Oncotarget

Volumn 6, Issue 23, 2015, Pages 19780-19791

  Lourdusamy, Anbarasu ^a   Rahman, Ruman ^a   Grundy, Richard G ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

Co expression network; Ependymoma; Gene expression; Meta analysis

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; TUMOR MARKER;

ADULT; ARTICLE; BRD1 GENE; CHILD; CHROMOSOME 22; CONTROLLED STUDY; DNA REPAIR; DOWN REGULATION; EP300 GENE; EPENDYMOMA; GENE; GENE EXPRESSION PROFILING; GENE LOCATION; GLIA CELL; HDAC10 GENE; HIC2 GENE; HIRA GENE; HUMAN; HUMAN TISSUE; INTRACRANIAL EPENDYMOMA; INTRACRANIAL TUMOR; MAJOR CLINICAL STUDY; MKL1 GENE; NERVE CELL DIFFERENTIATION; NF2 GENE; OXIDATIVE STRESS; SCHOOL CHILD; SIGNAL TRANSDUCTION; SPINAL CORD TUMOR; SPINAL EPENDYMOMA; YOUNG ADULT; BIOLOGY; BRAIN TUMOR; CELL AGING; CLUSTER ANALYSIS; COMPARATIVE STUDY; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETIC DATABASE; GENETIC PREDISPOSITION; GENETICS; METABOLISM; PATHOLOGY; PHENOTYPE; PROCEDURES; SPINE TUMOR; TUMOR SUPPRESSOR GENE;

BIOMARKERS, TUMOR; BRAIN NEOPLASMS; CELL AGING; CHROMOSOMES, HUMAN, PAIR 22; CLUSTER ANALYSIS; COMPUTATIONAL BIOLOGY; DATABASES, GENETIC; EPENDYMOMA; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; GENES, NEUROFIBROMATOSIS 2; GENETIC PREDISPOSITION TO DISEASE; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; SPINAL NEOPLASMS;

EID: 84939228678     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.3715     Document Type: Article

References (43)

1. Hasselblatt M. Ependymal tumors. Recent results in cancer research Fortschritte der Krebsforschung Progres dans les recherches sur le cancer. 2009; 171:51-66.
2. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007; 114:97-109.
3. Abul-Kasim K, Thurnher MM, McKeever P and Sundgren PC. Intradural spinal tumors: current classification and MRI features. Neuroradiology. 2008; 50:301-314.
4. Cooper PR. Outcome after operative treatment of intramedullary spinal cord tumors in adults: intermediate and long-term results in 51 patients. Neurosurgery. 1989; 25:855-859.
5. Helseth A and Mork SJ. Primary intraspinal neoplasms in Norway, 1955 to 1986. A population-based survey of 467 patients. Journal of neurosurgery. 1989; 71:842-845.
6. Parsa AT, Lee J, Parney IF, Weinstein P, McCormick PC and Ames C. Spinal cord and intradural-extraparenchymal spinal tumors: current best care practices and strategies. Journal of neuro-oncology. 2004; 69:291-318.
7. Ruda R, Gilbert M and Soffietti R. Ependymomas of the adult: molecular biology and treatment. Current opinion in neurology. 2008; 21:754-761.
8. Ebert C, von Haken M, Meyer-Puttlitz B, Wiestler OD, Reifenberger G, Pietsch T and von Deimling A. Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas. The American journal of pathology. 1999; 155:627-632.
9. Lamszus K, Lachenmayer L, Heinemann U, Kluwe L, Finckh U, Hoppner W, Stavrou D, Fillbrandt R and Westphal M. Molecular genetic alterations on chromosomes 11 and 22 in ependymomas. International journal of cancer Journal international du cancer. 2001; 91:803-808.
10. Singh PK, Gutmann DH, Fuller CE, Newsham IF and Perry A. Differential involvement of protein 4.1 family members DAL-1 and NF2 in intracranial and intraspinal ependymomas. Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc. 2002; 15:526-531.
11. Korshunov A, Neben K, Wrobel G, Tews B, Benner A, Hahn M, Golanov A and Lichter P. Gene expression patterns in ependymomas correlate with tumor location, grade, and patient age. The American journal of pathology. 2003; 163:1721-1727.
12. Lukashova-v Zangen I, Kneitz S, Monoranu CM, Rutkowski S, Hinkes B, Vince GH, Huang B and Roggendorf W. Ependymoma gene expression profiles associated with histological subtype, proliferation, and patient survival. Acta Neuropathol. 2007; 113:325-337.
13. Palm T, Figarella-Branger D, Chapon F, Lacroix C, Gray F, Scaravilli F, Ellison DW, Salmon I, Vikkula M and Godfraind C. Expression profiling of ependymomas unravels localization and tumor grade-specific tumorigenesis. Cancer. 2009; 115:3955-3968.
14. Taylor MD, Poppleton H, Fuller C, Su X, Liu Y, Jensen P, Magdaleno S, Dalton J, Calabrese C, Board J, Macdonald T, Rutka J, Guha A, Gajjar A, Curran T and Gilbertson RJ. Radial glia cells are candidate stem cells of ependymoma. Cancer cell. 2005; 8:323-335.
15. Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, Barrette T, Pandey A and Chinnaiyan AM. Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proceedings of the National Academy of Sciences of the United States of America. 2004; 101:9309-9314.
16. de Magalhaes JP, Curado J and Church GM. Meta-analysis of age-related gene expression profiles identifies common signatures of aging. Bioinformatics. 2009; 25:875-881.
17. Schwartzbaum JA, Fisher JL, Aldape KD and Wrensch M. Epidemiology and molecular pathology of glioma. Nature clinical practice Neurology. 2006; 2:494-503; quiz 491 p following 516.
18. Kilari D and Mohile SG. Management of cancer in the older adult. Clinics in geriatric medicine. 2012; 28:33-49.
19. Campisi J. Aging, cellular senescence, and cancer. Annual review of physiology. 2013; 75:685-705.
20. Tacutu R, Budovsky A, Yanai H and Fraifeld VE. Molecular links between cellular senescence, longevity and age-related diseases - a systems biology perspective. Aging. 2011; 3:1178-1191.
21. Hulsebos TJM, Oskam NT, Bijleveld EH, Westerveld A, Hermsen MA, van den Ouweland AMW, Hamel BC and Tijssen CC. Evidence for an ependymoma tumour suppressor gene in chromosome region 22pter-22q11.2. Brit J Cancer. 1999; 81:1150-1154.
22. Kraus JA, de Millas W, Sorensen N, Herbold C, Schichor C, Tonn JC, Wiestler OD, von Deimling A and Pietsch T. Indications for a tumor suppressor gene at 22q11 involved in the pathogenesis of ependymal tumors and distinct from hSNF5/INI1. Acta Neuropathol. 2001; 102:69-74.
23. Begnami MD, Palau M, Rushing EI, Santi M and Quezado M. Evaluation of NF2 gene deletion in sporadic schwannomas, meningiomas, and ependymomas by chromogenic in situ hybridization. Hum Pathol. 2007; 38:1345-1350.
24. Birch BD, Johnson JP, Parsa A, Desai RD, Yoon JT, Lycette CA, Li YM and Bruce JN. Frequent type 2 neurofibromatosis gene transcript mutations in sporadic intramedullary spinal cord ependymomas. Neurosurgery. 1996; 39:135-140.
25. Wellik DM. Hox patterning of the vertebrate axial skeleton. Developmental dynamics: an official publication of the American Association of Anatomists. 2007; 236:2454-2463.
26. Cillo C, Faiella A, Cantile M and Boncinelli E. Homeobox genes and cancer. Experimental cell research. 1999; 248:1-9.
27. Lopez-Otin C, Blasco MA, Partridge L, Serrano M and Kroemer G. The hallmarks of aging. Cell. 2013; 153:1194-1217.
28. Bretscher A, Chambers D, Nguyen R and Reczek D. ERMMerlin and EBP50 protein families in plasma membrane organization and function. Annual review of cell and developmental biology. 2000; 16:113-143.
29. Giordano A and Avantaggiati ML. p300 and CBP: partners for life and death. Journal of cellular physiology. 1999; 181:218-230.
30. Chan HM and La Thangue NB. p300/CBP proteins: HATs for transcriptional bridges and scaffolds. Journal of cell science. 2001; 114:2363-2373.
31. Iyer NG, Ozdag H and Caldas C. p300/CBP and cancer. Oncogene. 2004; 23:4225-4231.
32. Rajendran R, Garva R, Ashour H, Leung T, Stratford I, Krstic-Demonacos M and Demonacos C. Acetylation mediated by the p300/CBP-associated factor determines cellular energy metabolic pathways in cancer. International journal of oncology. 2013; 42:1961-1972.
33. Johnson RA, Wright KD, Poppleton H, Mohankumar KM, Finkelstein D, Pounds SB, Rand V, Leary SE, White E, Eden C, Hogg T, Northcott P, Mack S, Neale G, Wang YD, Coyle B, et al. Cross-species genomics matches driver mutations and cell compartments to model ependymoma. Nature. 2010; 466:632-636.
34. Witt H, Mack SC, Ryzhova M, Bender S, Sill M, Isserlin R, Benner A, Hielscher T, Milde T, Remke M, Jones DT, Northcott PA, Garzia L, Bertrand KC, Wittmann A, Yao Y, et al. Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma. Cancer cell. 2011; 20:143-157.
35. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U and Speed TP. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003; 4:249-264.
36. Ramasamy A, Mondry A, Holmes CC and Altman DG. Key issues in conducting a meta-analysis of gene expression microarray datasets. PLoS medicine. 2008; 5:e184.
37. Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Statistical applications in genetics and molecular biology. 2004; 3:Article3.
38. Laliberté E. (2011). metacor: Meta-analysis of correlation coefficients. R package version).
39. Carmona-Saez P, Chagoyen M, Tirado F, Carazo JM and Pascual-Montano A. GENECODIS: a web-based tool for finding significant concurrent annotations in gene lists. Genome biology. 2007; 8:R3.
40. Supek F, Bosnjak M, Skunca N and Smuc T. REVIGO summarizes and visualizes long lists of gene ontology terms. PloS one. 2011; 6:e21800.
41. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES and Mesirov JP. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences of the United States of America. 2005; 102:15545-15550.
42. Lage K, Karlberg EO, Storling ZM, Olason PI, Pedersen AG, Rigina O, Hinsby AM, Tumer Z, Pociot F, Tommerup N, Moreau Y and Brunak S. A human phenome-interactome network of protein complexes implicated in genetic disorders. Nature biotechnology. 2007; 25:309-316.
43. Rossin EJ, Lage K, Raychaudhuri S, Xavier RJ, Tatar D, Benita Y, International Inflammatory Bowel Disease Genetics C, Cotsapas C and Daly MJ. Proteins encoded in genomic regions associated with immune-mediated disease physically interact and suggest underlying biology. PLoS genetics. 2011; 7:e1001273.